First-line catheter ablation of paroxysmal atrial fibrillation: Outcome of radiofrequency vs. cryoballoon pulmonary vein isolation

Europace

Volumn 18, Issue 3, 2016, Pages 368-375

  Straube, Florian ^a   Dorwarth, Uwe ^a   Ammar Busch, Sonia ^b   Peter, Timo ^c   Noelker, Georg ^d   Massa, Thomas ^e   Kuniss, Malte ^f   Ewertsen, Niels Christian ^g   Chun, Kyoung Ryul Julian ^h   Tebbenjohanns, Juergen ⁱ   Tilz, Roland ^j   Kuck, Karl Heinz ^j   Ouarrak, Taoufik ^k   Senges, Jochen ^k   Hoffmann, Ellen ^a  

^a Munich Municipal Hospital   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c KRH Klinikum Siloah Oststadt Heidehaus   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^f KERCKHOFF HEART CENTER   (Germany)

^g VIVANTES KLINIKUM AM URBAN   (Germany)

^h CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

ⁱ HELIOS Klinikum Hildesheim   (Germany)

^j DEPARTMENT OF CARDIOLOGY   (Germany)

^k IHF   (Germany)

more..

Author keywords

Catheter ablation; Clinical outcome; Cryoballoon; Efficacy; First line; Paroxysmal atrial fibrillation; Radiofrequency ablation; Safety

Indexed keywords

ADULT; AGED; ANEURYSM; ARTERIOVENOUS FISTULA; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; CARDIOVERSION; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CRYOBALLOON PULMONARY VEIN ISOLATION; DEATH; FEMALE; FOLLOW UP; GROIN HEMATOMA; HEART INFARCTION; HEART TAMPONADE; HOSPITAL DISCHARGE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PAROXYSMAL ATRIAL FIBRILLATION; PHRENIC NERVE PARALYSIS; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; RADIATION EXPOSURE; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; RETREATMENT; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT DURATION; TREATMENT OUTCOME; ACTION POTENTIAL; ADVERSE EFFECTS; CLINICAL TRIAL; CRYOSURGERY; EUROPE; HEART RATE; MIDDLE AGED; MULTICENTER STUDY; OPERATION DURATION; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PULMONARY VEIN; RADIATION DOSE; REGISTER; REOPERATION; RISK FACTOR; SOUTH AFRICA; TIME FACTOR; UNITED STATES;

ACTION POTENTIALS; AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; CRYOSURGERY; EUROPE; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; OPERATIVE TIME; PROSPECTIVE STUDIES; PULMONARY VEINS; RADIATION DOSAGE; RADIATION EXPOSURE; RECURRENCE; REGISTRIES; REOPERATION; RISK FACTORS; SOUTH AFRICA; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84965121106     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euv271     Document Type: Article

References (22)

1. January CT,Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr. et al. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014;64:e1-76.
2. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14:1385-413.
3. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: A randomized trial. JAMA 2005;293:2634-40.
4. Morillo CA, Verma A, Connolly SJ, Kuck KH, Nair GM, Champagne J et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): A randomized trial. JAMA 2014;311:692-700.
5. Cosedis Nielsen J, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med 2012;367:1587-95.
6. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14:528-606.
7. Schmidt M, Dorwarth U, Andresen D, Brachmann J, Kuck KH, Kuniss M et al. Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German Ablation Registry. J Cardiovasc Electrophysiol 2014;25:1-7.
8. Straube F, Dorwarth U, Schmidt M,Wankerl M, Ebersberger U, Hoffmann E. Comparison of the first and second cryoballoon: high-volume single-center safety and efficacy analysis. Circ Arrhythm Electrophysiol 2014;7:293-9.
9. Straube F, Dorwarth U, Vogt J, Kuniss M, Heinz Kuck K, Tebbenjohanns J et al. Differences of two cryoballoon generations: insights from the prospective multicentre, multinational FREEZE Cohort Substudy. Europace 2014;16:1434-42.
10. Furnkranz A, Bordignon S, Dugo D, Perotta L, Gunawardene M, Schulte-Hahn B et al. Improved 1-year clinical success rate of pulmonary vein isolation with the second-generation cryoballoon in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2014;25:840-4.
11. Chierchia GB, Di Giovanni G, Ciconte G, de Asmundis C, Conte G, Sieira-Moret J et al. Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: 1-year follow-up. Europace 2014;16:639-44.
12. Metzner A, Reissmann B, Rausch P, Mathew S,Wohlmuth P, Tilz R et al. One-year clinical outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Circ Arrhythm Electrophysiol 2014;7:288-92.
13. Reddy VY, Sediva L, Petru J, Skoda J, Chovanec M, Chitovova Z et al. Durability of pulmonary vein isolation with cryoballoon ablation: results from the Sustained PV Isolation with Arctic Front Advance (SUPIR) Study. J Cardiovasc Electrophysiol 2015; 26:493-500.
14. Piccini JP, Lopes RD, Kong MH, Hasselblad V, Jackson K, Al-Khatib SM. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: A meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol 2009;2: 626-33.
15. Cheng X, Hu Q, Zhou C, Liu LQ, Chen T, Liu Z et al. the long-term efficacy of cryoballoon vs irrigated radiofrequency ablation for the treatment of atrial fibrillation: A meta-analysis. Int J Cardiol 2014;181C:297-302.
16. Hoffmann E, Dorwarth U, Kuck KH, Vogt J, Kuniss M, Schneider S et al. Design and baseline patient characteristics of the prospective, observational, multicenter and multinational cohort study comparing radiofrequency with cryoablation for pulmonary vein isolation in patients with atrial fibrillation-The Freeze Cohort Study. Int J Clin Med 2014;5:1161-72.
17. Cappato R, Calkins H, Chen SA, DaviesW, Iesaka Y, Kalman J et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:32-8.
18. Camm AJ. Safety considerations in the pharmacological management of atrial fibrillation. Int Jo Cardiol 2008;127:299-306.
19. Letsas KP, Efremidis M, Giannopoulos G, Deftereos S, Lioni L, Korantzopoulos P et al. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation. Europace 2014;16:202-7.
20. Reddy VY, Shah D, Kautzner J, Schmidt B, Saoudi N, Herrera C et al. the relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm 2012;9: 1789-95.
21. Kautzner J, Neuzil P, Lambert H, Peichl P, Petru J, Cihak R et al. EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation. Europace 2015;17:1229-35.
22. Picano E, Vano E, Rehani MM, Cuocolo A, Mont L, Bodi V et al. the appropriate and justified use of medical radiation in cardiovascular imaging: A position document of the ESC Associations of Cardiovascular Imaging, Percutaneous Cardiovascular Interventions and Electrophysiology. Eur Heart J 2014;35: 665-72.